Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/16/20
End: 12/13/21
Due: 12/13/22
Phase: N/A
Priority: Normal
Start: 12/07/18
End: 06/22/21
Due: 06/22/22
Phase: N/A
Priority: Normal
Start: 12/04/19
End: 05/11/21
Due: 05/11/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis | NCT04503746 | AngioLab, Inc. | user2@example.com | None | 2020-07-16 | 2021-12-13 | 2022-12-13 | - | - | 2025-07-14 |
| Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD | NCT03725501 | AngioLab, Inc. | user2@example.com | None | 2018-12-07 | 2021-06-22 | 2022-06-22 | - | - | 2025-07-14 |
| A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH | NCT04342793 | AngioLab, Inc. | user2@example.com | None | 2019-12-04 | 2021-05-11 | 2022-05-11 | - | - | 2025-07-14 |